Xiangyu Kong

A nano-integrated diagnostic and therapeutic platform with oxidation–reduction reactions in tumor microenvironments

Nan Liu, Wenzhi Liu, Fengkai Ruan, 2020, Nanoscale advances.

Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.

Feng-jie Qi, Xiangyu Kong, Yongxing Zhang, 2015, International journal of clinical and experimental pathology.

Epac1 is involved in cell cycle progression in lung cancer through PKC and Cx43 regulation.

Wenzhi Liu, Youliang Yao, Xiaoxuan Chen, 2015, Folia histochemica et cytobiologica.

Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells

Xiaoxuan Chen, Yue Dai, Suhang Hua, 2016, Scientific Reports.

Correlation between the protein expression levels of A‐kinase anchor protein95, p‐retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues

Shuo Wang, Youliang Yao, Zhiyu Guan, 2019, Asia-Pacific journal of clinical oncology.

PDE4 and Epac1 Synergistically Promote Rectal Carcinoma via the cAMP Pathway

Wenzhi Liu, Youliang Yao, Feng-jie Qi, 2019, Analytical cellular pathology.

Association of Inflammation-Related Gene Polymorphisms With Susceptibility and Radiotherapy Sensitivity in Head and Neck Squamous Cell Carcinoma Patients in Northeast China

Xia Li, Ye Zhang, Ying Li, 2021, Frontiers in Oncology.

Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.

Wenzhi Liu, Binbin Chen, Qian Sun, 2018, Current molecular pharmacology.

Epac1 is involved in cell cycle progression in lung cancer through PKC and Cx43 regulation.

Wenzhi Liu, Youliang Yao, Xiaoxuan Chen, 2015, Folia histochemica et cytobiologica.